-- Mazor Jumps to 3-Month High as FDA Approves Brain Procedures
-- B y   D a v i d   W a i n e r
-- 2012-07-16T13:48:43Z
-- http://www.bloomberg.com/news/2012-07-16/mazor-jumps-to-3-month-high-as-fda-approves-brain-procedures-1-.html
Mazor Robotics Ltd. (MZOR)  advanced to the
highest level in three months after receiving approval from the
U.S. Food and Drug Administration to market its Renaissance
system for brain surgery procedures.  The  shares  gained 9.3 percent to 4.645 shekels at the close
in Tel Aviv, the highest since April 11.  To contact the reporter on this story:
David Wainer in Tel Aviv at 
 dwainer3@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  